Stuart Roberts

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study

P. Gow, S. Bell, G. McCaughan, 2022, Hepatology International.

Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study

P. Gow, S. Bell, G. McCaughan, 2022, Hepatology International.

Advancing the global public health agenda for NAFLD: a consensus statement

Myeong Jun Song, R. Malekzadeh, V. Wong, 2021, Nature Reviews Gastroenterology & Hepatology.

Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy

P. Angus, J. George, S. Locarnini, 2017, Liver international : official journal of the International Association for the Study of the Liver.

The case for simplifying and using absolute targets for viral hepatitis elimination goals

R. Malekzadeh, C. Richter, Chien-Jen Chen, 2020, Journal of viral hepatitis.

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Jisoo A. Kwon, R. Malekzadeh, F. Tacke, 2023, The lancet. Gastroenterology & hepatology.